VRDN Latest Headlines

Wells Fargo Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)

at www.tipranks.com (Mon, 20-Jul 5:55 AM)

Viridian Therapeutics Raises $350 Million Through Upsized Convertible Notes and Equity Offerings—Strategic Moves Fuel Robust Pipeline Expansion

Market Chameleon (Thu, 7-May 8:17 AM)

Viridian’s Launch-Ready Pipeline: Veligrotug PDUFA Date Nears and Elegrobart Emerges as First Potential At-Home TED Autoinjector

Market Chameleon (Tue, 5-May 10:32 AM)

Viridian Therapeutics Prepares for TED Launch with Positive Clinical Data and $762M Cash Reserve

Market Chameleon (Tue, 5-May 8:02 AM)